The related mechanism shows that in glioma, PRMT6 is recruited by the transcriptional regulator CDK9 to the YTHDF2 promoter region and then synergistically promotes the transcriptional activation of YTHDF2 with CDK9. Here, YTHDF2 is linked to central nervous system cancer.